JP2010511704A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511704A5
JP2010511704A5 JP2009540246A JP2009540246A JP2010511704A5 JP 2010511704 A5 JP2010511704 A5 JP 2010511704A5 JP 2009540246 A JP2009540246 A JP 2009540246A JP 2009540246 A JP2009540246 A JP 2009540246A JP 2010511704 A5 JP2010511704 A5 JP 2010511704A5
Authority
JP
Japan
Prior art keywords
formula
metal ion
group
represented
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009540246A
Other languages
English (en)
Japanese (ja)
Other versions
JP5340953B2 (ja
JP2010511704A (ja
Filing date
Publication date
Priority claimed from US11/633,139 external-priority patent/US8287839B2/en
Application filed filed Critical
Publication of JP2010511704A publication Critical patent/JP2010511704A/ja
Publication of JP2010511704A5 publication Critical patent/JP2010511704A5/ja
Application granted granted Critical
Publication of JP5340953B2 publication Critical patent/JP5340953B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009540246A 2006-12-04 2007-12-03 カルボラニルポルフィリンとその使用 Expired - Fee Related JP5340953B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/633,139 2006-12-04
US11/633,139 US8287839B2 (en) 2006-12-04 2006-12-04 Carboranylporphyrins and uses thereof
PCT/US2007/024767 WO2008133664A2 (en) 2006-12-04 2007-12-03 Carboranylporphyrins and uses thereof

Publications (3)

Publication Number Publication Date
JP2010511704A JP2010511704A (ja) 2010-04-15
JP2010511704A5 true JP2010511704A5 (cg-RX-API-DMAC7.html) 2011-01-13
JP5340953B2 JP5340953B2 (ja) 2013-11-13

Family

ID=39476019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540246A Expired - Fee Related JP5340953B2 (ja) 2006-12-04 2007-12-03 カルボラニルポルフィリンとその使用

Country Status (17)

Country Link
US (2) US8287839B2 (cg-RX-API-DMAC7.html)
EP (1) EP2099304B1 (cg-RX-API-DMAC7.html)
JP (1) JP5340953B2 (cg-RX-API-DMAC7.html)
CN (1) CN101605459B (cg-RX-API-DMAC7.html)
AU (1) AU2007352392B2 (cg-RX-API-DMAC7.html)
CA (1) CA2671849C (cg-RX-API-DMAC7.html)
CY (1) CY1115816T1 (cg-RX-API-DMAC7.html)
DK (1) DK2099304T3 (cg-RX-API-DMAC7.html)
ES (1) ES2504173T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009005904A (cg-RX-API-DMAC7.html)
NZ (1) NZ577386A (cg-RX-API-DMAC7.html)
PL (1) PL2099304T3 (cg-RX-API-DMAC7.html)
PT (1) PT2099304E (cg-RX-API-DMAC7.html)
RU (1) RU2477161C2 (cg-RX-API-DMAC7.html)
SI (1) SI2099304T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008133664A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903906B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113391A2 (en) * 2012-02-02 2013-08-08 Brainlab Ag Method for determining an infusion parameter
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment
GB201221125D0 (en) * 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
CN104151339B (zh) * 2013-05-17 2017-05-03 中国科学院近代物理研究所 含硼吖啶衍生物、其制备方法和应用
CN103936747B (zh) * 2014-04-18 2016-06-22 济南大学 一种烷基取代树枝状金属卟啉及其制备方法和应用
WO2016125359A1 (ja) * 2015-02-03 2016-08-11 ソニー株式会社 情報処理装置、情報処理方法およびプログラム
JP6699004B2 (ja) * 2015-08-25 2020-05-27 住友重機械工業株式会社 中性子捕捉療法システム及び中性子捕捉療法システムの制御方法
IT202000001048A1 (it) 2020-01-21 2021-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.
CN112358494B (zh) * 2020-04-09 2021-09-28 南京大学 一种基于吖啶的碳硼烷衍生物及其在生物显影中的应用
CN113735886B (zh) * 2020-05-13 2022-06-03 北京大学 Pdt化合物及其制备方法和用途
IT202100001049A1 (it) 2021-01-21 2022-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.
CN116333037A (zh) * 2021-12-17 2023-06-27 化学与精细化工广东省实验室 含巯基肽与氟代卟啉类偶联用作生物探针

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824659A (en) 1985-06-07 1989-04-25 Immunomedics, Inc. Antibody conjugates
US4783529A (en) 1985-12-03 1988-11-08 Research Corporation Technologies Rapid synthesis of radiolabeled porphyrin complexes for medical application
US5672334A (en) 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5707604A (en) 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5162231A (en) 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
US4892941A (en) 1987-04-17 1990-01-09 Dolphin David H Porphyrins
US4977268A (en) 1988-04-08 1990-12-11 Duke University Boron dipeptide compounds
US4959356A (en) 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
FR2656866B1 (fr) 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5654423A (en) 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
US5149801A (en) 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5312896A (en) 1992-10-09 1994-05-17 Sri International Metal ion porphyrin-containing poly(imide)
DE4305523A1 (de) 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5466679A (en) 1993-05-17 1995-11-14 The Ohio State University Research Foundation Carboranyl uridines and their use in boron neutron capture therapy
US5489673A (en) 1993-08-16 1996-02-06 University Of Washington Iodinated borane cage molecules as X-ray contrast media
US5599796A (en) 1993-12-02 1997-02-04 Emory University Treatment of urogenital cancer with boron neutron capture therapy
JPH07330773A (ja) * 1994-06-07 1995-12-19 Toyo Hatsuka Kogyo Kk ポルフィリン誘導体とその用途
US5563132A (en) 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
JP2685128B2 (ja) * 1995-07-21 1997-12-03 東北大学長 カルボラン含有ガドリニウム−ｄｔｐａ錯体、その中間体、およびこれらの製造方法
US5877165A (en) 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5776925A (en) 1996-01-25 1998-07-07 Pharmacyclics, Inc. Methods for cancer chemosensitization
US5955586A (en) 1996-03-22 1999-09-21 Sessler; Jonathan L. Highly boronated derivatives of texaphyrins
US6375930B2 (en) 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
US6270749B1 (en) 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
WO1998030102A1 (en) 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6010805A (en) 1998-05-26 2000-01-04 United States Of America As Represented By The Secretary Of The Air Force Ion conducting electrolyte material containing a lithium porphyrin complex
BR0016114B1 (pt) * 1999-12-03 2008-11-18 mÉtodo e aparelho de revestimento de uma superfÍcie de substrato em movimento.
US7067653B2 (en) 2000-05-09 2006-06-27 The Regents Of The University Of California Porphyrin Based neuton capture agents for cancer therapy
US6765092B2 (en) 2000-07-21 2004-07-20 North Carolina State University Regioisomerically pure oxochlorins and methods of synthesis
FR2812637B1 (fr) 2000-08-01 2002-10-25 Anulm Ass Nantaise Pour L Util Nouveaux composes derives de dihydroporphyrine et leurs applications
JP4944348B2 (ja) 2000-09-08 2012-05-30 三栄源エフ・エフ・アイ株式会社 テトラフェニルバクテリオクロリン誘導体およびそれを含む組成物
US6849607B2 (en) 2001-05-09 2005-02-01 Health Research, Inc. Galectin recognized photosensitizers for photodynamic therapy
CA2448570A1 (en) 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
US6566517B2 (en) 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
EP1404319B1 (en) * 2001-06-06 2006-03-22 Brookhaven Science Associates Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
EP1279676A1 (en) 2001-07-19 2003-01-29 Institut Curie Porphyrin derivatives for photodynamic therapy
US20040019095A1 (en) 2002-01-29 2004-01-29 Ziwei Xiao N, N'-dimethylated N-confused porphyrins
US7087214B2 (en) 2002-02-01 2006-08-08 Zentaris Gmbh Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
RU2236411C2 (ru) * 2002-06-06 2004-09-20 Московская государственная академия тонкой химической технологии им. М.В. Ломоносова Металлокомплексы карборанилпорфиринов, обладающие противоопухолевой активностью
AU2003262833A1 (en) 2002-08-23 2004-03-11 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent glycosides and methods for their use
GB0222945D0 (en) 2002-10-03 2002-11-13 Psimei Pharmaceuticals Plc Therapeutic compositions
US7267990B2 (en) 2002-11-15 2007-09-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Chelation of charged and uncharged molecules with porphyrin-based compounds
ITFI20030063A1 (it) * 2003-03-11 2004-09-12 Molteni & C Metallo ftalocianine boronate, loro preparazione, composizioni
US6995260B2 (en) 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
US6989443B2 (en) 2004-06-28 2006-01-24 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
GB0415663D0 (en) * 2004-07-13 2004-08-18 Psimei Pharmaceuticals Plc Compound
GB0427589D0 (en) * 2004-12-16 2005-01-19 Psimei Pharmaceuticals Plc Process for the preparation of a substituted porphyrin
US7582751B2 (en) * 2005-07-29 2009-09-01 North Carolina State University Methods and intermediates for the synthesis of porphyrins

Similar Documents

Publication Publication Date Title
JP2010511704A5 (cg-RX-API-DMAC7.html)
RU2009121323A (ru) Карборанилпорферины и их применение
KR100899752B1 (ko) 신규한 금속포르피린 및 방사선요법용 방사선감작제로서의이의 용도
CN1279907C (zh) 新的金属卟啉化合物及其在放射疗法中用作放射增敏剂的用途
JP2008505983A5 (cg-RX-API-DMAC7.html)
JP2008504365A5 (cg-RX-API-DMAC7.html)
US9750809B2 (en) Cancer treatment
JP2014177421A (ja) 陽子線治療用増感剤、及びそれを用いた陽子線治療法
Kawabata et al. Clinical study on modified boron neutron capture therapy for newly diagnosed glioblastoma
HK1242977A1 (en) Carboranylporphyrins for use in the treatment of cancer
Slattery et al. Improved computational characterization of the thermal neutron source for neutron capture therapy research at the University of Missouri
HK1210023B (en) Carboranylporphyrins for use in the treatment of cancer
HK1078472B (en) Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
HK1133552B (en) Carboranylporphyrins and uses thereof